Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-08

FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals Inc., representing an approval of a labeling/indication …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)